XNSE
ALPA
Market cap18mUSD
Nov 12, Last price
85.15INR
Name
Alpa Laboratories Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1967 and based in Indore, India, Alpa Laboratories Limited specializes in the development and marketing of a diverse portfolio of finished pharmaceutical dosage forms. Their extensive product range includes ethical, generic, and over-the-counter (OTC) medications, presented as injections, tablets, capsules, eye/ear drops, ointments, creams, and gels, catering to both human and veterinary needs. The company's therapeutic categories are broad, encompassing anti-infectives (such as antibacterials, antibiotics, antifungals, antiprotozoals, and antivirals), analgesics, anti-inflammatory drugs, cough and cold remedies, cardiovascular medications, anti-diabetics, nutritional supplements, psychotropic treatments, and dermatological, ophthalmic, and otic preparations. Alpa Laboratories distributes its products throughout India through a network of distributors, retail chemists, pharmacies, and hospitals. Additionally, the company maintains an international presence, exporting to regions including South and Central America, Africa, Asia, Russia, Ukraine, and Kazakhstan.
Valuation
Title INR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||